Obesity Associated With Risk of Dissimilar Breast Cancers

Article

High body mass index (BMI) and low levels of physical activity are associated with increased risk of triple-negative and estrogen receptor-positive (ER+) breast cancers in postmenopausal women, according to a study published online March 1 in Cancer Epidemiology, Biomarkers & Prevention.

WEDNESDAY, March 2 (HealthDay News) -- High body mass index (BMI) and low levels of physical activity are associated with increased risk of triple-negative and estrogen receptor-positive (ER+) breast cancers in postmenopausal women, according to a study published online March 1 in Cancer Epidemiology, Biomarkers & Prevention.

Amanda I. Phipps, from the Fred Hutchinson Cancer Research Center in Seattle, and colleagues analyzed data from 155,723 women enrolled in the Women's Health Initiative, of whom 307 had triple-negative breast cancer and 2,610 had ER+ breast cancer. Baseline BMI, BMI earlier in adulthood, waist and hip circumference, and physical activity were analyzed to determine if they were associated with the risk of triple-negative and ER+ breast cancers.

The researchers found that women with BMI in the highest quartile had a 35 percent increased risk of developing triple-negative breast cancers compared to those in the lowest quartile, and a 39 percent increased risk of developing ER+ breast cancers. Waist and hip circumferences showed a positive association with ER+, but not with triple-negative breast cancer. Women who reported rates of physical activity in the highest tertile had a 23 percent decreased risk of triple-negative breast cancer and a 15 percent decreased risk of ER+ breast cancer.

"The results of this analysis suggest the existence of modest but modifiable risk factors for postmenopausal triple-negative breast cancer," the authors write. "These factors were similarly associated with lower risk of ER+ breast cancer, suggesting that the protective effects of these exposures are not breast cancer subtype-specific."

Related Content

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
Non-hormonal treatments offer relief for genitourinary syndrome of menopause | Image Credit: providers.uthscsa.edu.
Jill Liss, MD, MSCP, FACOG, associate clinical professor, OB/GYN, at the University of Colorado School of Medicine.
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Jennifer Payne, MD, highlights how to help young women with perimenopause symptoms | Image Credit: uvahealth.com/findadoctor.
Worse menopause symptom burden reported in rural women | Image Credit: uwmedicine.org.
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.